TARRYTOWN, N.Y. , Oct. 26, 2023 via IBN PaxMedica, Inc. a clinical-stage biopharmaceutical company, is excited to announce that the Annals of General Psychiatry, an internationally.
PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.